Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza® in Patients With Type II Diabetes

NCT03421119 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Liraglutide 6 MG/ML Pen Injector
DRUG: Metformin
DRUG: Sulfonylurea/non-sulfonylurea insulin secretagogues

Sponsor

Cinnagen